American Well Corporation (AMWL)
| Market Cap | 211.76M +82.3% |
| Revenue (ttm) | 218.53M -19.0% |
| Net Income | -78.11M |
| EPS | -4.74 |
| Shares Out | 17.01M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 57,251 |
| Open | 12.90 |
| Previous Close | 12.94 |
| Day's Range | 12.42 - 13.23 |
| 52-Week Range | 3.71 - 14.19 |
| Beta | 1.70 |
| Analysts | Hold |
| Price Target | 12.80 (+2.81%) |
| Earnings Date | Aug 4, 2026 |
About AMWL
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into th... [Read more]
Financial Performance
In 2025, American Well's revenue was $249.33 million, a decrease of -1.98% compared to the previous year's $254.36 million. Losses were -$95.70 million, -54.02% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for AMWL stock is "Hold." The 12-month stock price target is $12.8, which is an increase of 2.81% from the latest price.
News
Amwell price target raised to $12 from $7.50 at Truist
Truist raised the firm’s price target on Amwell (AMWL) to $12 from $7.50 and keeps a Hold rating on the shares. The firm is updating its model after the company’s…
Amwell makes grant to new employees under inducement plan
BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwe...
Amwell price target raised to $13 from $6.50 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Amwell (AMWL) to $13 from $6.50 and keeps an Equal Weight rating on the shares. Revenue estimates have been stabilizing and management…
Amwell price target raised to $12 from $8 at TD Cowen
TD Cowen raised the firm’s price target on Amwell (AMWL) to $12 from $8 and keeps a Hold rating on the shares. The firm said 2Q rev/adj. EBITDA beat driven…
Amwell price target raised to $11 from $6.50 at Stifel
Stifel raised the firm’s price target on Amwell (AMWL) to $11 from $6.50 and keeps a Hold rating on the shares. Q2 revenue and EBITDA beat on stronger-than-expected subscription revenue…
American Well Earnings Call Transcript: Q2 2026
Q2 2026 saw sequential subscription revenue growth and improved margins, despite a year-over-year revenue decline. The company is on track for positive adjusted EBITDA and cash flow breakeven in Q4, supported by a major DHA contract and strong pipeline momentum.
American Well Earnings release: Q2 2026
American Well released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
American Well Quarterly report: Q2 2026
American Well has published its Q2 2026 quarterly earnings report on August 4, 2026.
Amwell reports Q2 EPS (59c), consensus (60c)
Reports Q2 revenue $52.05M, consensus $49.88M. “The DHA’s intent to make Amwell (AMWL) a prime contractor is a powerful endorsement of our platform and our people,” said Ido Schoenberg, Chairman…
Amwell® Announces Results for the Second Quarter 2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the seco...
Amwell® to report second quarter 2026 operating results
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 o...
Amwell price target raised to $16 from $9 at Wells Fargo
Wells Fargo analyst Stephen Baxter raised the firm’s price target on Amwell (AMWL) to $16 from $9 and keeps an Overweight rating on the shares. DHA’s Notice of Intent appears…
American Well Transcript: AGM 2026
Shareholders addressed director election, auditor ratification, and executive compensation. Roy Schoenberg resigned from the board, and quorum was confirmed. Final voting results will be filed on Form 8-K.
American Well Proxy statement: Proxy filing
American Well filed a proxy statement on June 9, 2026, providing details for shareholder voting and corporate governance matters.
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
BOSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today highlighted results from an ...
American Well Transcript: 21st Annual Needham Technology, Media, & Consumer Conference
The company has transformed to focus on payer and government markets, achieving strong Q1 results with higher subscription and visit revenues, improved margins, and significant cost reductions. Major government contracts and payer renewals are set to drive growth and margin expansion, with AI adoption supporting further efficiencies.
Amwell® to Participate in Upcoming Investor Conference
BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschho...
Amwell price target raised to $6.50 from $6 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Amwell (AMWL) to $6.50 from $6 and keeps an Equal Weight rating on the shares. Revenue upside in the quarter and tighter…
Amwell price target raised to $8 from $5 at TD Cowen
TD Cowen analyst Charles Rhyee raised the firm’s price target on Amwell (AMWL) to $8 from $5 and keeps a Hold rating on the shares. The firm said the company…
American Well Earnings Call Transcript: Q1 2026
Revenue declined 18% year-over-year in Q1 2026, but gross margin remained strong and cost discipline led to a significant reduction in losses. Renewals and pipeline growth were robust, with confidence in achieving cash flow breakeven in Q4 and multi-year growth ahead.
American Well Earnings release: Q1 2026
American Well released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
American Well Quarterly report: Q1 2026
American Well has published its Q1 2026 quarterly earnings report on May 5, 2026.
Amwell® Announces Results for First Quarter 2026
BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results ...
American Well Proxy statement: Proxy filing
American Well filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
American Well Proxy statement: Proxy filing
American Well filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.